JXR buys back additional 4.14 million shares; cumulative repurchases hit 94.48 million under 2025 mandate

Bulletin Express06-05

Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share, spending HK$9.38 million in aggregate. The volume-weighted average price was approximately HK$2.27 per share. All of the shares will be cancelled.

Following the latest transaction, shares bought back under the mandate granted on 26 June 2025 total 94.48 million, representing 3.44 % of the company’s issued share capital at the time the mandate was approved.

As at the disclosure date, 54.82 million repurchased shares are pending cancellation, equal to roughly 2.03 % of JXR’s current issued share base of 2.71 billion shares. The reported transactions leave the company with sufficient headroom to repurchase a further 179.99 million shares before reaching the 10 % limit authorised by shareholders.

A 30-day moratorium applies to any new share issuance or sale of treasury shares up to 5 July 2026, in accordance with Hong Kong Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154627200?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154627200","market":"hk","top_or_hot":-1,"title":"JXR buys back additional 4.14 million shares; cumulative repurchases hit 94.48 million under 2025 mandate","media":"Bulletin Express","content":"<p>Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share, spending HK$9.38 million in aggregate. The volume-weighted average price was approximately HK$2.27 per share. All of the shares will be cancelled.</p>\n<p>Following the latest transaction, shares bought back under the mandate granted on 26 June 2025 total 94.48 million, representing 3.44 % of the company’s issued share capital at the time the mandate was approved.</p>\n<p>As at the disclosure date, 54.82 million repurchased shares are pending cancellation, equal to roughly 2.03 % of JXR’s current issued share base of 2.71 billion shares. The reported transactions leave the company with sufficient headroom to repurchase a further 179.99 million shares before reaching the 10 % limit authorised by shareholders.</p>\n<p>A 30-day moratorium applies to any new share issuance or sale of treasury shares up to 5 July 2026, in accordance with Hong Kong Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JXR buys back additional 4.14 million shares; cumulative repurchases hit 94.48 million under 2025 mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJXR buys back additional 4.14 million shares; cumulative repurchases hit 94.48 million under 2025 mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share, spending HK$9.38 million in aggregate. The volume-weighted average price was approximately HK$2.27 per share. All of the shares will be cancelled.</p>\n<p>Following the latest transaction, shares bought back under the mandate granted on 26 June 2025 total 94.48 million, representing 3.44 % of the company’s issued share capital at the time the mandate was approved.</p>\n<p>As at the disclosure date, 54.82 million repurchased shares are pending cancellation, equal to roughly 2.03 % of JXR’s current issued share base of 2.71 billion shares. The reported transactions leave the company with sufficient headroom to repurchase a further 179.99 million shares before reaching the 10 % limit authorised by shareholders.</p>\n<p>A 30-day moratorium applies to any new share issuance or sale of treasury shares up to 5 July 2026, in accordance with Hong Kong Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01951","symbol_name":"锦欣生殖","start_time":0,"source_url":"","article_id":"1154627200","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154627200","pubTimestamp":1780652656,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01951":"锦欣生殖"},"translate_title":"JXR额外回购414万股；2025年授权累计回购达9448万笔","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01951":1},"content_text":"Jinxin Fertility Group Limited (JXR) disclosed that on 5 June 2026 it repurchased 4.14 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$2.25 to HK$2.28 per share, spending HK$9.38 million in aggregate. The volume-weighted average price was approximately HK$2.27 per share. All of the shares will be cancelled.\nFollowing the latest transaction, shares bought back under the mandate granted on 26 June 2025 total 94.48 million, representing 3.44 % of the company’s issued share capital at the time the mandate was approved.\nAs at the disclosure date, 54.82 million repurchased shares are pending cancellation, equal to roughly 2.03 % of JXR’s current issued share base of 2.71 billion shares. The reported transactions leave the company with sufficient headroom to repurchase a further 179.99 million shares before reaching the 10 % limit authorised by shareholders.\nA 30-day moratorium applies to any new share issuance or sale of treasury shares up to 5 July 2026, in accordance with Hong Kong Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154627200","isCrawlerRequest":true}